A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131)
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the study medication blood levels after administration
of a single oral capsule of Bendavia at one of three dose levels. The effects of Bendavia on
the volunteers will also be assessed.